Malaysian Consumer Association Urges Ban on E-Cigarettes and GIE

Dec.01.2022
Malaysian Consumer Association Urges Ban on E-Cigarettes and GIE
Consumer Association of Penang urges Malaysian government to ban e-cigarette products and adopt a generational ban on cigarette sales.

The Consumers Association of Penang (CAP) in Malaysia is urging the incoming government to adopt the intergenerational ban (GEG) as soon as possible to prohibit the sale of tobacco products to people born after 2007. They are also calling for a complete ban on electronic nicotine delivery systems (ENDS).


Photo courtesy of NST.


Allowing the use of electronic cigarettes may pose a significant problem of addiction to drugs for future generations. In November 2019, CAP warned that "e-cigarettes should be banned rather than regulated, as it is impossible to monitor the market for hundreds of legal and illegal e-cigarette brands and verify the ingredients in these e-liquids.


In early November, the federal police in Bukit Aman confirmed concerns over openly selling electronic cigarettes. As such, the incoming government should take action to implement a generational ban and fully prohibit e-cigarette products. The reason being that e-liquids containing illegal drugs can be packaged in bottles with counterfeit labels. The government cannot realistically monitor the products being sold by approximately 3,000 domestic e-cigarette retailers.


Regulators say that part of the reason for this is that the US Food and Drug Administration has not yet reviewed the ingredients or established standards. There are many different ingredients and flavors in various electronic cigarette brands. Some e-liquids may contain illegal drugs such as tetrahydrocannabinol and cannabidiol (both compounds of marijuana), N,N-Dimethylacetamide, gamma-hydroxybutyrate, and ketamine.


The components of e-cigarette liquid may need to be tested using gas chromatography and mass spectrometry, which can only be found in modern analytical chemistry laboratories. These tests are expensive, and are an unnecessary financial burden for governments.


A study conducted in Malaysia in 2017 revealed that 54% of the surveyed e-cigarette users obtained zero-nicotine e-liquids from the black market, while 30% obtained homemade e-liquids. The government should not be naïve in thinking that there is no black market for e-liquids. In fact, e-liquids can be easily produced with basic equipment.


How can the government differentiate between legitimate e-liquids and illicit drug liquids packaged in e-cigarette devices? Therefore, the CAP once again urges the incoming government to enforce a generational ban, including a comprehensive ban on e-cigarette products.


2FIRSTS will continue to cover this topic and future updates will be posted on the '2FIRSTS APP'. Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA has released the final batch of materials for ZYN MRTP applications and set March 4 (11:59 p.m. ET) as the deadline for public comments to be considered in the agency’s review.
Feb.03 by 2FIRSTS.ai
Reuters Exclusive: FDA’s Fast-Track Review of Nicotine Pouches Slows Over Youth and New-User Concerns
Reuters Exclusive: FDA’s Fast-Track Review of Nicotine Pouches Slows Over Youth and New-User Concerns
Reuters reported on April 1 that several popular nicotine pouch products still have not been cleared for sale in the United States despite a fast-track review pilot run by the U.S. Food and Drug Administration. Three sources said FDA reviewers have taken a cautious approach because of potential risks to youth and other non-tobacco users, including the possibility of driving nicotine addiction among adults who do not already smoke.
Apr.02 by 2FIRSTS.ai
Brazil’s Teen E-Cigarette Experimentation Rate Rises to 29.6% Over Five Years
Brazil’s Teen E-Cigarette Experimentation Rate Rises to 29.6% Over Five Years
Brazil’s National School Health Survey (PeNSE) 2024 found that e-cigarette experimentation among students aged 13 to 17 rose from 16.8% in 2019 to 29.6% in 2024, while use in the previous 30 days increased from 8.6% to 26.3%. Over the same period, conventional cigarette experimentation fell from 22.6% to 18.5%, and hookah use declined from 26.9% to 16.4%.
Mar.26 by 2FIRSTS.ai
UK’s North Yorkshire Council plans up to £477,000 spend on e-cigarettes to support quitting smoking
UK’s North Yorkshire Council plans up to £477,000 spend on e-cigarettes to support quitting smoking
North Yorkshire Council in the UK is set to spend up to £477,000 on e-cigarettes to support residents quitting smoking. Since e-cigarettes were added to the council’s Living Well Smokefree service in July 2023, 487 people have used them to quit, with about a third remaining smoke-free after a year.
Mar.03 by 2FIRSTS.ai
PMI says Colorado ZYN plant build advances as first pouches hit market in 2025
PMI says Colorado ZYN plant build advances as first pouches hit market in 2025
Philip Morris International (PMI) is investing $600 million to build a ZYN nicotine pouch plant in Aurora, Colorado. While the facility is still under construction, PMI said production started in September 2025 and the first pouches made at the site have already gone to market.
Feb.10 by 2FIRSTS.ai
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11